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Abstract 
Although eosinophils are inflammatory cells, there is increasing attention on their immunomodulatory 
roles. For example, murine eosinophils can present antigen to CD4+ T helper (Th) cells, but it remains 
unclear whether human eosinophils also have this ability. This study determined whether human 
eosinophils present a range of antigens, including allergens, to activate Th cells, and characterized their 
expression of MHC class II and co-stimulatory molecules required for effective presentation. 
Human peripheral blood eosinophils purified from non-allergic donors were pulsed with the antigens house 
dust mite extract (HDM), Timothy Grass extract (TG) or Mycobacterium tuberculosis purified protein 
derivative (PPD), before co-culture with autologous CD4+ Th cells. Proliferative and cytokine responses 
were measured, with eosinophil expression of HLA-DR/DP/DQ and the co-stimulatory molecules CD40, 
CD80 and CD86 determined by flow cytometry. Eosinophils pulsed with HDM, TG or PPD drove Th cell 
proliferation, with the response strength dependent on antigen concentration. The cytokine responses 
varied with donor and antigen, and were not biased towards any particular Th subset, often including 
combinations of pro- and anti-inflammatory cytokines. Eosinophils up-regulated surface expression of HLA-
DR/DP/DQ, CD80, CD86 and CD40 in culture, increases that were sustained over 5 days when incubated 
with antigens, including HDM, or the major allergens it contains, Der p I or Der p II. Human eosinophils can, 
therefore, act as effective antigen-presenting cells to stimulate varied Th cell responses against a panel of 
antigens including HDM, TG or PPD, an ability that may help to determine the development of allergic 
disease. 
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 Introduction  
Eosinophil involvement in inflammatory conditions affecting the skin, gastrointestinal tract and upper and 
lower airways is well-documented.(1, 2)  Asthma is now recognised as a heterogeneous condition with a 
number of phenotypes, some of which are stratified according to cellular infiltrates such as neutrophilic or 
eosinophilic asthma.(3)  Eosinophilic asthma is characterized by increased blood or sputum eosinophils, (4) 
the numbers of which correlate with disease severity.(5)  Infiltrating tissue eosinophils release their potent 
pro-inflammatory arsenal that includes such diverse elements as granule-derived basic proteins, lipid 
mediators, cytokines and chemokines.(2)  These contribute to airway inflammation and lung tissue 
remodelling, including epithelial cell damage and loss, airway thickening, fibrosis and angiogenesis.(6)  In 
addition to their role as degranulating effector cells, more recent findings emphasise the 
immunomodulatory properties of eosinophils,(7) and other important effector functions such as a potential 
role in maintaining host survival in life-threatening respiratory viral infections.(8) 
 
One question that has attracted interest is whether eosinophils can modulate immune responses by acting 
as antigen presenting cells (APC) to stimulate CD4+ helper T (Th) cell responses.  It has been known for 
many years that in vitro culture of eosinophils with GM-CSF, typically added to prevent their apoptosis, can 
also induce expression of MHC Class II,(9) which could equip them for antigen presentation.  MHC Class II 
expression by eosinophils has been observed in murine models of allergic airways inflammation(10) and 
intraperitoneal parasitic infection.(11)  In man, tissue eosinophils have increased MHC Class II expression,(12) 
with upregulation observed in asthma,(13) chronic eosinophilic pneumonia(14) and eosinophilic 
esophagitis.(15) 
 
Consistent with APC function, murine eosinophils home to lymphoid tissue and provide a second signal for 
T cell activation through the expression of key co-stimulatory molecules such as CD80 and CD86.(16, 17)  
Although it has been demonstrated that human eosinophils can express CD86 when taken from 
hypereosinophilic patients,(18) or stimulated with IL-3,(19) it is unclear how commonly, or in what 
circumstances, they display such co-stimulatory molecules.  There are also reports that human eosinophils 
can process and present antigen to activate specific T cells,(20) but, again, it remains to be established how 
widespread is such ability in different individuals and for different antigens.  Despite the evidence that 
eosinophils have the potential to act as APC to drive Th cell responses and thereby propagate 
inflammation,(21, 22) other findings have suggested that this is limited to super-antigens and peptides, rather 
than proteins that require processing.(11, 16)  The effects of Th activation are critically dependent on the 
subset(s) that respond, and the associated cytokines they produce, but it is not known whether eosinophil 
antigen presentation preferentially supports responses by any particular Th type. 
 
To address the unanswered questions about their roles as APC, we performed a comprehensive 
examination of the ability of purified peripheral blood human eosinophils to present a variety of protein 
antigens to autologous CD4+ Th cells.  Helper responsiveness was tested to eosinophils pulsed with the 
allergens house dust mite extract (HDM), Timothy Grass extract (TG), Der p 1 Der p 2, or the microbial recall 
antigen Mycobacterium tuberculosis purified protein derivative (PPD), with eosinophil expression of MHC 
Class II molecules and the co-stimulatory molecules CD40, CD80 and CD86 characterized.  It was also 
determined whether any Th cytokines elicited by eosinophil antigen presentation exhibited a bias towards 
particular effector or regulatory subsets.  The focus here was on donors with no history of allergy, since we 
wished to establish the ability of eosinophils to contribute to the Th activation in the absence of any pre-
existing strong pathogenic response. 
 
 
Methods 
Materials 
CD-16 immunomagnetic beads, the Human CD4+T Cell Isolation Kit II and magnetically activated separation 
columns were from Miltenyi Biotec (Surrey, UK).  HDM (Dermatophagoides pteronyssinus) and TG extracts, 
(both certified LPS free and obtained from NIBSC, UK) were dialysed using slide-A- Lyzer dialysis cassettes 
(Thermo scientific, UK) for 24 hours and used at a final concentrations of 500—2500 IU/ml.  PPD (Satens 
Serum Institute, Denmark) was added to cell cultures at a final concentration of 5 µg/ml.  
Dermatophagoides pteronyssinus allergens, Der p 1 or Der p 2 (Indoor Biotechnologies Ltd) were used at 
final concentrations 10 µg/ml.  All cells were cultured in RPMI 1640 (Labtech International Ltd, UK) 
supplemented with HEPES and 100 IU/ml penicillin, 100 µg/ml streptomycin, L- glutamine 5% (v/v) (Gibco, 
Life Technologies, Paisley, UK) and 5% (v/v) heat-inactivated autologous serum, with 10nM granulocyte-
macrophage colony-stimulating factor (rhGM-CSF, R&D systems, Abingdon, UK).  The latter was essential to 
prevent eosinophil apoptosis during co-culture. The following mAb were used in these studies: HLA-
DR/DP/DQ (clone TL2.1), CD1a (clone H1149), CD40 (clone5 C3), CD80 (L307.4) and CD86 (clone 2331) were 
all from BD Pharmingen, Oxford, UK. Siglec-8 mAb (clone 7CP) was from Biolegend, London, UK.  Cytokine 
levels were measured by Multiplex array for IFN-γ, IL-3, IL-6, IL-10, IL-17A and TNF-α (Luminex, Millipore, 
Watford, UK) and by ELISA for IL-9 and IL-13 (Biolegend). 
 
Eosinophil and Th cell Isolation 
Human eosinophils and CD4+ Th cells were purified from individuals with no clinical history of allergy or 
eosinophilia (< 0.5 x 106 eosinophils/ml), and who were not taking any medication for allergic disease.  The 
inclusion of patients with hemochromatosis, who were being routinely bled to treat the disease, allowed 
relatively large numbers of eosinophils for some experiments to be collected from whole units of blood in 
the face of normal eosinophil counts.  All subjects gave informed consent and the study was approved by 
the North of Scotland Research Ethics Service (ref 09/S0801/16).  Eosinophils were purified from samples of 
peripheral blood using our standard technique(22) using dextran sedimentation and centrifugation on 
Percoll gradients followed by CD16-dependent negative immunomagnetic selection.  To obtain CD4+ Th 
cells, peripheral blood mononuclear cells (PBMC) were isolated by density gradient centrifugation(23) and 
non-target cells depleted by negative selection following the manufacturer’s instructions. 
 
Using these methods, eosinophils and Th cells with respective purities of at least 98% were obtained, with 
greater than 98% viability as assessed by trypan blue exclusion. 
 
Cell cultures 
Eosinophils (5x105/ml) were incubated in culture medium for up to 5 days in the presence of rhGM-CSF (10 
nM) to inhibit their spontaneous apoptosis as previously described,(24) with or without the addition of 
antigens.  When co-cultured with autologous CD4+ Th cells, eosinophils were first pulsed with antigens by 
overnight incubation, then washed and added at 5x105/ml in medium containing GM-CSF to the Th cells 
(1x106/ml) for 5 days; these conditions were found to give optimal Th responses in pilot experiments (data 
not shown).  Cultures of autologous PBMC (1.25x106/ml), with or without antigen, provided controls for 
comparison of Th responsiveness.  
 
Th cell responses 
Proliferative Th cell responses were determined by incorporation of 3H-thymidine in triplicate 100μl 
volumes withdrawn from cultures 5 days after stimulation as previously described, with results presented 
as CPM.(25)  Cytokine levels in cultures were measured by bead array for IFN-γ, IL-3, IL-6, IL-10, IL-17A and 
TNF-α and by ELISA for IL-9 and IL-13, according to the manufacturers’ instructions.  Cytokine responses >2x 
background in unstimulated wells were considered significant.(23)  To test the dependency of responses on 
MHC class II,(26) antigen-pulsed eosinophils were incubated with blocking antibody before co-culture with 
autologous CD4+ Th cells. 
 
Immunostaining and flow cytometry 
Cell surface expression markers were examined using flow cytometry for HLA-DR,-DP,-DQ, and co-
stimulatory molecules, CD40, CD80, and CD86 using established protocols.(22)  Briefly, eosinophils and CD4+ 
Th cells were removed from co-culture, washed and saturating quantities of primary antibodies or specific 
isotype controls were added to the cells and incubated for 40 min at 40C in the dark, washed and fixed.  
Human dendritic cells (DC) were identified by staining cells with CD1a while eosinophils were identified by 
staining with a specific marker, siglec-8.(27)  Multiple panels of conjugated antibodies were used to identify 
the subpopulation of immune cells and the corresponding specific cell surface markers. Ten thousand 
events were collected on flow cytometer, LSRII (BD Biosciences) using FACS Diva software (BD Biosciences). 
Analysis was performed using FlowJo software (Treestar, Inc., Ashland, Oreg. USA). 
 
 
 
Statistics 
Data were analyzed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA), and since D’Agostino-Person 
Omnibus and Shapiro-Wilk normality tests were failed, non-parametric methods were used (Wilcoxon-
Signed-Rank-test or Mann-Whitney U Test as appropriate).  Bonferoni correction was applied to correct for 
multiple comparisons.  Data were considered to be statically significant if p<0.05, and are expressed as 
either median and interquartile range (IQR), or individual data points if n<4. 
 
Results 
Eosinophils pulsed with antigen induce proliferative Th responses 
We first examined the ability of human eosinophils pulsed with a range of concentrations of the allergens 
HDM or TG, or with our standard concentration of the control microbial recall antigen PPD, to induce 
proliferation by autologous CD4+ Th cells after 5 days of co-culture.  In a series of 9 experiments, significant 
(p<0.001) increases in proliferation were observed when eosinophils had been pulsed by pre-incubation 
with the allergens HDM (Figure 1A) or TG (Figure 1B) at final concentrations of 1000, 1500 or 2500 IU/ml, 
compared with medium alone.  The strongest responses were induced by HDM or TG at 2500 IU, and this 
concentration of the allergens was therefore used in all subsequent experiments.  Eosinophils pulsed with 
the control antigen PPD also elicited significant proliferation at the standard concentration of 5 µg/ml.  To 
confirm that responses to each stimulus required the presence of both eosinophils and Th cells, 
proliferation was compared in cultures containing each cell type alone or together, with or without antigen 
pulsing (Figure 2).  Proliferative responses were significant only when both antigen-pulsed eosinophils and 
Th cells were added, and, strikingly, these responses were similar in size to those seen when unfractionated 
PBMC were stimulated with the respective antigen.  The ability of Th cells to respond to antigen-pulsed 
eosinophils was MHC class II dependent, since incubating HDM-pulsed eosinophils with blocking mAb 
specific for HLA-DR/DP/DQ(26) significantly (P<0.001) reduced T cell proliferation by 77% (Supplemental 
Figure 1). 
 Figure 1.  Eosinophils pulsed with allergen stimulate Th cell proliferative responses.  Panels show 
proliferation in co-cultures of peripheral blood CD4+ Th cells and autologous eosinophils that have been 
pulsed with the antigens HDM (A), TG (B), or PPD (C).  Results are expressed as median CPM and IQR from 9 
independent experiments (*p < 0.01, Mann-Whitney U-test with Bonferroni correction). 
 
Figure 2.  Eosinophils pulsed with antigen stimulate Th proliferation comparable to PBMC responses.  
Panels show proliferation in cultures containing peripheral blood CD4+ Th cells and autologous eosinophils, 
either alone or together, with or without pulsing of the eosinophils with the antigens HDM (A), TG (B) or 
PPD (C).  Proliferation in PBMC cultures, either untreated or antigen stimulated, is included for comparison.  
Eo = purified eosinophils, T = purified CD4+ T cells (*p<0.05, Mann Whitney U-test with Bonferroni 
correction). 
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 Supplemental Figure 1. Blockade of HLA-DR/DP/DQ inhibits HDM induced Th cell proliferation.  Panels 
show proliferation in co-cultures of peripheral blood CD4+ Th cells and autologous eosinophils that have 
been pulsed with different combinations of HDM or blocking anti-HLA-DR/DP/DQ monoclonal antibody.  
Results are expressed as median CPM and IQR from 9 independent experiments (* p < 0.01, Mann-Whitney 
U-test). 
 
 
Eosinophil expression of MHC class II and co-stimulatory molecules 
Effective APC require expression of both MHC class II and co-stimulatory molecules, so we next tested 
whether cultured eosinophils display HLA-DR/DP/DQ and CD40, CD80 and CD86.  Examples of flow 
cytometric analyses, and graphical summaries of data from 9 independent experiments, demonstrate 
eosinophil expression of HLA-DR/DP/DQ (Figure 3) and CD40, CD80 and CD86 (Figure 4) during 5 day 
cultures, with or without HDM addition.  It can be seen that, within 24 hours, eosinophil expression of MHC 
class II, and the co-stimulatory molecules CD40, CD80 and CD86, was significantly increased in all cultures, 
an effect that may be at least partly due to the presence of GM-CSF added to the medium to prevent 
eosinophil apoptosis.(9)  However, there was a further effect of HDM.  Addition of the antigen sustained the 
elevated levels of MHC class II, CD40, CD80 and CD86 over the course of the incubation, since, without 
HDM, expression of all the markers fell back by day 5 to levels not significantly above those seen at the 
beginning of the culture. 
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Figure 3.  Cultured eosinophils express MHC class II.  Representative flow cytometric histograms (n=9) 
demonstate HLA DR/DP/DQ expression by purified eosinophils incubated with HDM at day 0 (A) and day 5 
(B) of culture (solid line = stained cells, dotted line = unstained cells, dashed line = isotype control).  The 
gate indicates the percentage of eosinophils staining positively for HLA-DR/DP/DQ.  HLA-DR/DP/DQ 
expression on unstimulated (C) or HDM stimulated (D) eosinophils over 5 days of culture is summarized in 
bar charts, with results expressed as median and IQR of % eosinophils positive for HLA DR\DP\DQ staining 
from 9 independent experiments (*p < 0.01, Mann Whitney U-test with Bonferroni correction).  
 
 
Figure 4.  Cultured eosinophils express costimulatory molecules.  Representative flow cytometric 
histograms (n=9) demonstate CD40 (A), CD80 (B) and CD86 (D) expression by purified eosinophils incubated 
with HDM at day 0 (left panels) and day 5 (right panels) of culture (solid line = stained cells, dotted line = 
unstained cells, dashed line = isotype control).  The gate indicates the percentage of eosinophils staining 
positively for each co-stimulatory molecule.  CD40 (D), CD80 (E) and CD86 (F) expression by unstimulated 
(left panels) or HDM stimulated (right panels) eosinophils over 5 days of culture is summarized in the bar 
charts, with results expressed as median and IQR of % eosinophils positive for each marker from 9 
independent experiments (*p < 0.01, Mann Whitney U-test with Bonferroni correction). 
 
The HDM preparation is a simple extract, so we next tested whether the major allergens it contains, Der p 1 
and Der p 2, recapitulate its ability to sustain enhanced expression of MHC class II and co-stimulatory 
molecules by eosinophils.  Eosinophils incubated with Der p 1 or Der p 2 exhibited similar sustained 
increases in expression of HLA-DR\DP\DQ, CD40, CD80 and CD86 compared with those elicited by the crude 
HDM preparation (Figure 5).  
 
                        
Figure 5. Der P1 and Der P2 antigens share the ability of HDM to sustain eosinophil surface expression of 
MHC class II and costimulatory molecules.  Comparision of the effects of incubation with the purified 
allergens Der p 1 or Der p 2, or the allergen extract HDM, on numbers of eosinophils that  express of 
HLADR\DP\DQ (A), CD40 (B), CD80 (C) and CD86 (D) after 5 days of culture.  Results are expressed as 
median and IQR of % eosinophils positive for each marker from 6 independent experiments (* p < 0.01, 
Mann-Whitney U-test with Bonferoni correction).  
 
Th cytokine responses induced by eosinophils pulsed with antigen 
Having demonstrated the ability of eosinophils to present antigen to drive Th proliferative responses, the 
question arises as to whether cytokines associated with any particular CD4+ subset are produced.  Signature 
cytokines for the major subsets Th1 (IFN-γ), Th2 (IL-13), Th9 (IL-9), Treg (IL-10), Th17 (IL-17A) and the 
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inflammatory cytokines TNF-α, IL-3 and IL-6, were measured in co-cultures of CD4+ Th cells and eosinophils 
with, or without, pulsing with the antigens HDM, TG or PPD.  Different patterns of cytokine response to the 
antigens were seen in cultures from each of the donors tested (n=6), with examples illustrated in Figure 6, 
and all results summarized in Table 1.  It can be seen that antigen-pulsed eosinophils are capable of eliciting 
a wide range of cytokines tested.  Although IL-6 production was the most frequently seen response, 
cultures of antigen-pulsed eosinophils could also contain complex mixtures of both pro- and anti-
inflammatory cytokines, and, overall, there was no clear or consistent bias towards any particular Th 
subset. 
              
Figure 6.  Production of multiple cytokines in co-cultures of CD4+ Th cells and antigen-pulsed eosinophils.  
Examples are shown (donors 1 and 5, n=6) of different patterns of cytokine secretion by co-cultures of CD4+ 
Th cells and eosinophils pulsed with the antigens HDM, TG or PPD. 
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  Stimulus S1 S2 S3 S4 S5 S6 
IFN-γ 
HDM       
TG       
PPD      nt 
TNF-α 
HDM       
TG       
PPD      nt 
IL-3 
HDM       
TG       
PPD      nt 
IL-6 
HDM       
TG       
PPD      nt 
IL-9 
HDM       
TG       
PPD      nt 
IL-10 
HDM       
TG       
PPD      nt 
IL-13 
HDM       
TG       
PPD      nt 
IL-17 
 
HDM       
TG       
PPD      nt 
 
Table 1: Cytokine production by co-cultures of Th cells and eosinophils presenting antigen.  The table 
shows whether there is an increase (up arrow, SI>2), decrease (down arrow, SI<0.5) or no change 
(horizontal arrows, SI range 0.5-2) in cytokine production in Th cell-eosinophil co-cultures when eosinophils 
are pulsed with HDM, TG or PPD, compared to unpulsed control.  nt=not tested 
 
Discussion 
The present study has established the ability of human eosinophils to present a wide variety of protein 
antigens, including allergens, to stimulate proliferative and cytokine responses by CD4+ Th cells.  In line with 
their ability to elicit responses to antigen, eosinophils exhibited upregulated MHC class II and costimulatory 
molecules in culture.  Since the donors tested here had no clinical history of allergy, the results raise the 
possibility that eosinophils acting as APC can help determine whether Th responses to allergen are elicited 
or become pathogenic. 
 
There is now a substantial body of evidence demonstrating that murine eosinophils presenting antigen 
have the ability to stimulate Th cells, including the induction of primary responses, and that they act as true 
professional APC in homing to lymph nodes, where they can interact with Th cells.(21)  We show here that 
human eosinophils are also effective APC for a variety of antigens in vitro, able to evoke Th proliferative 
responses comparable in magnitude to those seen when paired PMBC samples are challenged with the 
same antigen.  Thus, human eosinophil presentation to Th cells is limited neither to peptide antigens nor 
superantigens that do not require processing, as has been suggested,(11, 16) but may instead contribute to 
responses against many different proteins.  Whether such activity as APC in vitro is replicated in vivo 
remains to be established, but would be consistent with the increasingly accepted view that human 
eosinophils have immune regulatory, as well as effector, roles.(20, 21) 
 
APC function is dependent on display of MHC class II and costimulatory molecules.(28)  We not only confirm 
that cultured human eosinophils express HLA-DR/DP/DQ, but also show expression of all three major co-
stimulatory molecules, CD40, CD80 and CD86 by these cells.  Eosinophils in culture require addition of GM-
CSF to prevent apoptosis, and the presence of this cytokine is likely to have contributed to the APC 
phenotype seen here, since eosinophils purified from the spleens of IL-5 transgenic mice were also 
observed to express MHC Class II, CD40, CD80 and CD86 when stimulated with GM-CSF.(20)  Previous studies 
of human eosinophils have described upregulation of MHC class II and CD86 in response to cytokine or 
superantigen exposure(14, 19, 29), but, to our knowledge, we are the first to report expression of such a 
complete APC surface phenotype in cultured human eosinophils.  Although it could be argued that the 
precise conditions in vitro do not reflect those in vivo, the results nevertheless establish that eosinophils 
have the potential to present antigen very effectively, and the induction of APC function by stimuli such as 
GM-CSF in vivo may well represent an important mechanism by which eosinophils influence immune 
responses to allergens.  In addition, GM-CSF was not the only factor upregulating APC surface markers, 
since we demonstrated that the increases in the expression of HLA-DR/DP/DQ, CD40, CD80 and CD86 were 
sustained for up to 5 days of co-culture by eosinophils stimulated with whole HDM extract or the major 
HDM allergens Der p 1 and Der p 2.  A number of studies have identified similar effects of HDM extract or 
Der p 1 on other cell types.  For example, Der p 1 stimulation of monocyte-derived DC isolated from donors 
allergic to HDM increased CD86 expression, while control non-allergic subjects had significant increases in 
CD80 expression(30), and another study showed that Der p 1 stimulated human peripheral blood DC to 
increase expression of HLA-DR, CD80 and CD86.(31)  The underlying mechanisms remain to be established, 
but may include proteolytic activity of the allergen,(32) or its interaction with pattern recognition receptors. 
 Th cytokines elicited during responses to antigen play a key role in determining both protection from 
infection, and immune pathology.  Here, eosinophils acting as APC supported production of a wide range of 
Th cytokines that differed between individuals and antigens, but with no clear preference for any response 
type.  However, our study was of cells from donors with no clinical allergic disease, and so the possibility 
remains open that eosinophils may skew helper responses towards the pathogenic Th2 subset in patients 
with overt allergy, or a susceptibility to atopic disease.  The notion that eosinophils can drive a variety of Th 
subsets is supported by a previous study, which also tested co-cultures of human peripheral blood 
eosinophils and autologous CD4+ Th cells, and demonstrated both Th1 and Th2 cytokine responses to the 
super-antigen staphylococcal enterotoxin B (SEB).  These workers also demonstrated HLA-DR expression by 
peripheral blood eosinophils isolated from 50% of the subjects, attributed to GM-CSF added to cultures, but 
stimulation with SEB did not induce eosinophil expression of CD80 or CD86.(33)  The reasons for the 
differences between this result and the present study may well reflect the use of antigens versus polyclonal 
activator for stimulation.  Others have described the effect of stimulation with HDM antigen on eosinophil 
function.  For example, HDM stimulation of eosinophils in vitro led to production of IL-9 that may promote 
a Th2 immune response(34), but, although we detect this cytokine in some co-cultures of Th cells and 
antigen-pulsed eosinophils, HDM did not elicit the response more frequently than other antigens, and IL-9 
was not associated with any clear Th subset bias. 
 
Taken together, our data demonstrate that human eosinophils can act as effective APC to stimulate Th 
responses against a variety of antigens, including the allergens HDM or TG: a property that may contribute 
to the regulation of responses in vivo and to induction or control of pathology in allergic disease, depending 
on the cytokines elicited.  The findings add to the accumulating evidence that eosinophils possess more 
complex immunomodulatory roles in allergic disease than previously suspected.  Furthermore, any ability 
of HDM, Der p 1 or Der p 2 to act not only as antigens, but also to increase eosinophil co-stimulatory 
molecule expression, may enhance their immunogenicity.  Having demonstrated the ability of human 
eosinophils to present antigen, this study opens up new questions as to how important they are in 
initiating, skewing, amplifying or regulating allergic responses in patients. 
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